These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 837971)
21. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain. Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467 [No Abstract] [Full Text] [Related]
22. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors. Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092 [TBL] [Abstract][Full Text] [Related]
23. [Effects of an ergot derivative, lisuride, on the central dopaminergic system -- studies of behavioral pharmacology]. Hara K; Ikoma Y; Oshino N Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):1-13. PubMed ID: 7173731 [TBL] [Abstract][Full Text] [Related]
24. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice. Horowski R; Wachtel H Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166 [TBL] [Abstract][Full Text] [Related]
25. Effects of lisuride hydrogen maleate on ischemia-induced depletion of brain acetylcholine levels in gerbils. Ogawa N; Haba K; Yoshikawa H; Kawata M; Sato H Clin Ther; 1989; 11(2):241-6. PubMed ID: 2736570 [TBL] [Abstract][Full Text] [Related]
26. Monoamine metabolism during bicuculline-induced epileptic seizures in the rat. Calderini G; Carlsson A; Nordström CH Brain Res; 1978 Nov; 157(2):295-302. PubMed ID: 309780 [TBL] [Abstract][Full Text] [Related]
27. Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus. Kosar E; Sumová A; Jakoubek B Physiol Bohemoslov; 1986; 35(4):334-9. PubMed ID: 3020603 [TBL] [Abstract][Full Text] [Related]
28. Antagonism of a behavioral effect of LSD and lisuride in the cat. White FJ; Holohean AM; Appel JB Psychopharmacology (Berl); 1983; 80(1):83-4. PubMed ID: 6408677 [TBL] [Abstract][Full Text] [Related]
29. Ergot alkaloids and central monoaminergic receptors. Goldstein M J Pharmacol; 1985; 16 Suppl 3():19-24. PubMed ID: 3005775 [TBL] [Abstract][Full Text] [Related]
30. Catecholamine and 5-hydroxytryptamine synthesis and metabolism following intracerebroventricular injection of dibutyryl cyclic AMP. Debus G; Kehr W J Neural Transm; 1979; 45(3):195-206. PubMed ID: 225445 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride. Tissari AH; Atzori L; Galdieri MT Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):89-91. PubMed ID: 6843693 [TBL] [Abstract][Full Text] [Related]
32. Response of central monoaminergic neurons to lisuride: comparison with LSD. Rogawski MA; Aghajanian GK Life Sci; 1979 Apr; 24(14):1289-97. PubMed ID: 470543 [No Abstract] [Full Text] [Related]
33. Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist? Gerber R; Barbaz BJ; Martin LL; Neale R; Williams M; Liebman JM Neurosci Lett; 1985 Sep; 60(2):207-13. PubMed ID: 2997677 [TBL] [Abstract][Full Text] [Related]
34. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain. Goldstein M; Lew JY; Hata F; Lieberman A Gerontology; 1978; 24 Suppl 1():76-85. PubMed ID: 22480 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. Holohean AM; White FJ; Appel JB Eur J Pharmacol; 1982 Jul; 81(4):595-602. PubMed ID: 7117388 [TBL] [Abstract][Full Text] [Related]
36. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat. Hedner T; Lundborg P Med Biol; 1981 Aug; 59(4):212-23. PubMed ID: 6803074 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of neurotransmitter receptor binding by ergot derivatives. Hruska RE; Silbergeld EK J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611 [TBL] [Abstract][Full Text] [Related]
38. Effects of chronic administration of lisuride hydrogen maleate on aromatic amine and metabolite levels in the gerbil brain following bilateral common carotid ligation. Hirata H; Ogawa N; Haba K; Asanuma M; Chou H; Mori A Arch Int Pharmacodyn Ther; 1992; 315():5-15. PubMed ID: 1417364 [TBL] [Abstract][Full Text] [Related]
39. Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum. Saiani L; Trabucchi M; Tonon GC; Spano PF Neurosci Lett; 1979 Sep; 14(1):31-6. PubMed ID: 231228 [TBL] [Abstract][Full Text] [Related]
40. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. Broderick PA; Piercey MF J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]